{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T05:55:34Z","timestamp":1781502934562,"version":"3.54.1"},"reference-count":152,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    Tuberculosis remains a leading cause of global mortality, with the rise of multidrug resistant and extensively drug-resistant\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    strains highlighting an urgent need for novel therapeutics. The mycobacterial cell wall has long served as a validated drug target, owing to its unique architecture comprising arabinogalactan, peptidoglycan, and mycolic acids. This review provides a comprehensive overview of recent advances in cell wall targeting anti tuberculosis drug discovery, encompassing both established and emerging targets within the major biosynthetic pathways. Beyond conventional enzymatic inhibition, a multidimensional framework is explored that includes disrupting cell wall integrity through alternative mechanisms, interfering with energy metabolism and regulatory networks, blocking the secretion and transport of cell wall components, harnessing host-directed therapies and antimicrobial peptides, and leveraging nanotechnology-based delivery systems. By integrating discoveries across these diverse fronts, this review highlights evolving strategies and offers a forward looking perspective on the development of ultra short, highly effective, and resistance proof tuberculosis regimens.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2026.1863735","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T05:37:56Z","timestamp":1781501876000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Breaking the barrier: from biosynthetic inhibition to multidimensional modulation of the mycobacterial cell wall in tuberculosis therapy"],"prefix":"10.3389","volume":"17","author":[{"given":"Pan","family":"Li","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Chengdu Qingbaijiang District People\u2019s Hospital","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Public Health Clinical Center of Chengdu","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Chengdu Qingbaijiang District People\u2019s Hospital","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Chengdu Qingbaijiang District People\u2019s Hospital","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Chengdu Qingbaijiang District People\u2019s Hospital","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Chengdu Qingbaijiang District People\u2019s Hospital","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Chengdu Qingbaijiang District People\u2019s Hospital","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueliang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Chengdu Qingbaijiang District People\u2019s Hospital","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyong","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Chengdu Qingbaijiang District People\u2019s Hospital","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Han","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Chengdu Medical College","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3390\/molecules30030600","article-title":"Synthesis and antimycobacterial assays of some new ethambutol analogs","volume":"30","author":"Abdelaziz","year":"2025","journal-title":"Molecules"},{"key":"B2","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1017\/S0031182016002377","article-title":"Mycobacterial cell wall biosynthesis: a multifaceted antibiotic target","volume":"145","author":"Abrahams","year":"2016","journal-title":"Parasitology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1038\/s41467-023-39300-z","article-title":"DprE2 is a molecular target of the anti-tubercular nitroimidazole compounds pretomanid and delamanid","volume":"14","author":"Abrahams","year":"2023","journal-title":"Nat. Commun."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1080\/07391102.2020.1844061","article-title":"Weak spots inhibition in the Mycobacterium tuberculosis antigen 85C target for antitubercular drug design through selective irreversible covalent inhibitor-SER124","volume":"40","author":"Adewumi","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/ph15020197","article-title":"Sanders, pyrazole and triazole derivatives as Mycobacterium tuberculosis UDP-galactopyranose inhibitors","volume":"15","author":"Ahmed","year":"2022","journal-title":"Pharm. (Basel)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e202300971","DOI":"10.1002\/cbdv.202300971","article-title":"Novel antitubercular agents: design, synthesis, molecular dynamic and biological studies of pyrazole - 1,2,4-triazole conjugates","volume":"20","author":"Ajin","year":"2023","journal-title":"Chem. Biodivers."},{"key":"B7","doi-asserted-by":"publisher","first-page":"27709","DOI":"10.1038\/s41598-025-13329-0","article-title":"A computational approach to mycolic acid biosynthesis disruption in mycobacterium tuberculosis via molluscan metabolites as KasA inhibitors","volume":"15","author":"Alanzi","year":"2025","journal-title":"Sci. Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0103724","DOI":"10.1128\/aac.01037-24","article-title":"An arylsulfonamide that targets cell wall biosynthesis in mycobacterium tuberculosis. Antimicrob. Agents","volume":"68","author":"Allen","year":"2024","journal-title":"Chemother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"104486","DOI":"10.1016\/j.bioorg.2020.104486","article-title":"Design, synthesis and antimycobacterial evaluation of novel adamantane and adamantanol analogues effective against drug-resistant tuberculosis","volume":"106","author":"Alsayed","year":"2021","journal-title":"Bioorg. Chem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"7014","DOI":"10.1038\/s41598-023-34222-8","article-title":"An integrated computational approach towards novel drugs discovery against polyketide synthase 13 thioesterase domain of Mycobacterium tuberculosis","volume":"13","author":"Altharawi","year":"2023","journal-title":"Sci. Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1021\/acsinfecdis.5c00394","article-title":"Common biological properties of Mycobacterium tuberculosis MmpL3 inhibitors","volume":"11","author":"Ames","year":"2025","journal-title":"ACS. Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1080\/07391102.2023.2293276","article-title":"Virtual screening and identification of promising therapeutic compounds against drug-resistant Mycobacterium tuberculosis \u03b2-ketoacyl-acyl carrier protein synthase I (KasA)","volume":"43","author":"Andrianov","year":"2025","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0135923","DOI":"10.1128\/spectrum.01359-23","article-title":"In silico virtual screening for the identification of novel inhibitors against dihydrodipicolinate reductase (DapB) of Mycobacterium tuberculosis, a key enzyme of diaminopimelate pathway","volume":"11","author":"Angrish","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"B14","doi-asserted-by":"publisher","first-page":"115744","DOI":"10.1016\/j.bmc.2020.115744","article-title":"Inhibition of Mycobacterium tuberculosis InhA: design, synthesis and evaluation of new di-triclosan derivatives","volume":"28","author":"Armstrong","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1021\/acsinfecdis.9b00497","article-title":"Dimethylaminophenyl hydrazides as inhibitors of the lipid transport protein LprG in mycobacteria","volume":"6","author":"Bai","year":"2020","journal-title":"ACS. Infect. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1021\/acs.jmedchem.0c00107","article-title":"Optimization of hydantoins as potent antimycobacterial Decaprenylphosphoryl-\u03b2-d-Ribose oxidase (DprE1) inhibitors","volume":"63","author":"Balabon","year":"2020","journal-title":"J. Med. Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0098025","DOI":"10.1128\/aac.00980-25","article-title":"Thienopyrimidine amide analogs target MmpL3 in mycobacterium tuberculosis. Antimicrob. Agents","volume":"69","author":"Baldin","year":"2025","journal-title":"Chemother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"001345","DOI":"10.1099\/mic.0.001345","article-title":"Inoculum-dependent bactericidal activity of a Mycobacterium tuberculosis MmpL3 inhibitor","volume":"169","author":"Berube","year":"2023","journal-title":"Microbiol. Read."},{"key":"B19","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1021\/acsinfecdis.0c00735","article-title":"Structural and molecular dynamics of Mycobacterium tuberculosis malic enzyme, a potential Anti-TB drug target","volume":"7","author":"Burley","year":"2021","journal-title":"ACS. Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s11030-022-10436-2","article-title":"Computational design of MmpL3 inhibitors for tuberculosis therapy","volume":"27","author":"Chaitra","year":"2023","journal-title":"Mol. Divers."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1101\/2025.06.28.662095","article-title":"Mechanistic insights into the allosteric regulation of cell wall hydrolase RipA in Mycobacterium tuberculosis","author":"Carloni","year":"2025","journal-title":"bioRxiv"},{"key":"B22","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.colsurfb.2018.12.003","article-title":"Functionalized rifampicin-loaded nanostructured lipid carriers enhance macrophages uptake and antimycobacterial activity","volume":"175","author":"Carneiro","year":"2019","journal-title":"Colloids. Surf. B. Biointerfaces"},{"key":"B23","doi-asserted-by":"publisher","first-page":"102352","DOI":"10.1016\/j.tube.2023.102352","article-title":"GlfT1 down-regulation affects Mycobacterium tuberculosis biofilm formation and its in-vitro and in-vivo survival","volume":"141","author":"Chauhan","year":"2023","journal-title":"Tuberc. (Edinb)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"582416","DOI":"10.3389\/fcimb.2020.582416","article-title":"Biological profiling enables rapid mechanistic classification of phenotypic screening hits and identification of KatG activation-dependent pyridine carboxamide prodrugs with activity against Mycobacterium tuberculosis","volume":"10","author":"Chengalroyen","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"14430","DOI":"10.1021\/acsomega.1c01314","article-title":"Chemical space exploration of DprE1 inhibitors using chemoinformatics and artificial intelligence","volume":"6","author":"Chhabra","year":"2021","journal-title":"ACS. Omega."},{"key":"B26","doi-asserted-by":"publisher","first-page":"13782","DOI":"10.1021\/acsomega.3c08401","article-title":"Novel inhibitors to MmpL3 transporter of Mycobacterium tuberculosis by structure-based high-throughput virtual screening and molecular dynamics simulations","volume":"9","author":"Choksi","year":"2024","journal-title":"ACS. Omega."},{"key":"B27","doi-asserted-by":"publisher","first-page":"14158","DOI":"10.1021\/jacs.0c04376","article-title":"Synthetic-bioinformatic natural product antibiotics with diverse modes of action","volume":"142","author":"Chu","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"B28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejps.2017.12.006","article-title":"Mannose-functionalized solid lipid nanoparticles are effective in targeting alveolar macrophages","volume":"114","author":"Costa","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1021\/acs.jmedchem.3c01643","article-title":"Azetidines kill multidrug-resistant Mycobacterium tuberculosis without detectable resistance by blocking mycolate assembly","volume":"67","author":"Cui","year":"2024","journal-title":"J. Med. Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"117889","DOI":"10.1016\/j.ejmech.2025.117889","article-title":"Discovery of novel fluorescent amino-pyrazolines that detect and kill mycobacterium","volume":"297","author":"Cui","year":"2025","journal-title":"Tuberculosis. Eur. J. Med. Chem."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.GPP3-0027-2018","article-title":"Unraveling the structure of the mycobacterial envelope","volume":"7","author":"Daff\u00e9","year":"2019","journal-title":"Microbiol. Spectr."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e02693","DOI":"10.1016\/j.heliyon.2019.e02693","article-title":"Arabinosyltransferase C enzyme of Mycobacterium tuberculosis, a potential drug target: an insight from molecular docking study","volume":"6","author":"Das","year":"2020","journal-title":"Heliyon"},{"key":"B33","doi-asserted-by":"publisher","first-page":"120655","DOI":"10.1016\/j.ijpharm.2021.120655","article-title":"Clofazimine functionalized polymeric nanoparticles for brain delivery in the tuberculosis treatment","volume":"602","author":"de Castro","year":"2021","journal-title":"Int. J. Pharm."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e0012625","DOI":"10.1128\/aac.00126-25","article-title":"Targeting mycobacterial transpeptidases: evaluating the roles of Ldt and PBP inhibition in suppressing Mycobacterium smegmatis","volume":"69","author":"de Munnik","year":"2025","journal-title":"Antimicrob. Agents. Chemother."},{"key":"B35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/ph18010070","article-title":"Targeting the heart of mycobacterium: advances in anti-tubercular agents disrupting cell wall biosynthesis","volume":"18","author":"Diab","year":"2025","journal-title":"Pharmaceuticals"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/1873-3468.70021","article-title":"The multiple roles of the NlpC_P60 peptidase family in mycobacteria \u2013 an underexplored target for antimicrobial drug discovery","volume":"599","author":"Dos Santos Silva","year":"2025","journal-title":"FEBS. Lett."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e0352921","DOI":"10.1128\/mbio.03529-21","article-title":"Inhibiting Mycobacterium abscessus cell wall synthesis: using a novel diazabicyclooctane \u03b2-Lactamase inhibitor to augment \u03b2-Lactam action","volume":"13","author":"Dousa","year":"2022","journal-title":"mBio"},{"key":"B38","doi-asserted-by":"publisher","first-page":"115539","DOI":"10.1016\/j.ejmech.2023.115539","article-title":"Quinolone analogues of benzothiazinone: synthesis, antitubercular structure-activity relationship and ADME profiling","volume":"258","author":"Dube","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"B39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41579-019-0273-7","article-title":"The mycobacterial cell envelope \u2014 a moving target","volume":"18","author":"Dulberger","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e0143822","DOI":"10.1128\/aac.01438-22","article-title":"Pharmacokinetics and efficacy of the benzothiazinone BTZ-043 against tuberculous mycobacteria inside granulomas in the Guinea pig model","volume":"67","author":"Eckhardt","year":"2023","journal-title":"Antimicrob. Agents. Chemother."},{"key":"B41","doi-asserted-by":"publisher","first-page":"11779322241257039","DOI":"10.1177\/11779322241257039","article-title":"Targeting decaprenylphosphoryl-\u03b2-D-ribose 2\u2032-epimerase for innovative drug development against Mycobacterium tuberculosis drug-resistant strains","volume":"18","author":"El Haddoumi","year":"2024","journal-title":"Bioinform. Biol. Insights"},{"key":"B42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/10717544.2013.868556","article-title":"Niosomal encapsulation of ethambutol hydrochloride for increasing its efficacy and safety","volume":"22","author":"El-Ridy","year":"2015","journal-title":"Drug. Deliv."},{"key":"B43","doi-asserted-by":"publisher","first-page":"121369","DOI":"10.1016\/j.ijpharm.2021.121369","article-title":"Development of potent nanosized isatin-isonicotinohydrazide hybrid for management of Mycobacterium tuberculosis","volume":"612","author":"Eldehna","year":"2022","journal-title":"Int. J. Pharm."},{"key":"B44","doi-asserted-by":"publisher","first-page":"129189","DOI":"10.1016\/j.bmcl.2023.129189","article-title":"2-[(2-Amino-6-methylpyrimidin-4-yl)sulfanyl]-N-arylacetamides: discovery of a new class of anti-tubercular agents and prospects for their further structural modification","volume":"83","author":"Erkin","year":"2023","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B45","doi-asserted-by":"publisher","first-page":"112440","DOI":"10.1016\/j.ejmech.2020.112440","article-title":"Discovery of the first Mycobacterium tuberculosis MabA (FabG1) inhibitors through a fragment-based screening","volume":"200","author":"Fa\u00efon","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"B46","doi-asserted-by":"publisher","first-page":"14526","DOI":"10.1021\/acs.jmedchem.1c01049","article-title":"Structural and activity relationships of 6-Sulfonyl-8-Nitrobenzothiazinones as antitubercular agents","volume":"64","author":"Fan","year":"2021","journal-title":"J. Med. Chem."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.3390\/biomedicines11071975","article-title":"Side chain-modified benzothiazinone derivatives with anti-mycobacterial activity","volume":"11","author":"Fan","year":"2023","journal-title":"Biomedicines"},{"key":"B48","article-title":"GrcC1 mediates low-level resistance to multiple drugs","author":"Fang","year":"2025"},{"key":"B49","doi-asserted-by":"publisher","first-page":"115611","DOI":"10.1016\/j.ejmech.2023.115611","article-title":"2,6-Disubstituted 7-(naphthalen-2-ylmethyl)-7H-purines as a new class of potent antitubercular agents inhibiting DprE1","volume":"258","author":"Finger","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e0239354","DOI":"10.1371\/journal.pone.0239354","article-title":"InhA inhibitors have activity against non-replicating Mycobacterium tuberculosis","volume":"15","author":"Flint","year":"2020","journal-title":"PLoS. One."},{"key":"B51","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00894-023-05814-y","article-title":"S288T mutation altering MmpL3 periplasmic domain channel and H-bond network: a novel dual drug resistance mechanism","volume":"30","author":"Ge","year":"2024","journal-title":"J. Mol. Model."},{"key":"B52","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1021\/acsinfecdis.4c00808","article-title":"Identification of a series containing a pentafluorophenyl moiety that targets Pks13 to inhibit growth of Mycobacterium tuberculosis","volume":"11","author":"Green","year":"2025","journal-title":"ACS. Infect. Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"735166","DOI":"10.3389\/fmicb.2021.735166","article-title":"Dihydroartemisinin-loaded chitosan nanoparticles inhibit the rifampicin-resistant Mycobacterium tuberculosis by disrupting the cell wall","volume":"12","author":"Gu","year":"2021","journal-title":"Front. Microbiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"110597","DOI":"10.1016\/j.jbc.2025.110597","article-title":"The deacetylase NagA mediates the remodeling and recycling of peptidoglycan-derived amino sugars in mycobacteria","volume":"301","author":"Guy","year":"2025","journal-title":"J. Biol. Chem."},{"key":"B55","doi-asserted-by":"publisher","first-page":"18266","DOI":"10.1039\/d2ra02044k","article-title":"GlmU inhibitor from the roots of Euphorbia ebracteolata as an anti-tuberculosis agent","volume":"12","author":"Han","year":"2022","journal-title":"RSC. Adv."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e02020","DOI":"10.1128\/AAC.02020-19","article-title":"OPC-167832, a novel carbostyril derivative with potent antituberculosis activity as a DprE1 inhibitor","volume":"64","author":"Hariguchi","year":"2020","journal-title":"Antimicrob. Agents. Chemother."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e03315","DOI":"10.1128\/mBio.03315-19","article-title":"Peptidoglycan hydrolases RipA and Ami1 are critical for replication and persistence of Mycobacterium tuberculosis in the host","volume":"11","author":"Healy","year":"2020","journal-title":"mBio"},{"key":"B58","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.2147\/IDR.S221408","article-title":"The anti-mycobacterial activity of Ag, ZnO, and Ag- ZnO nanoparticles against MDR- and XDR-mycobacterium tuberculosis","volume":"12","author":"Heidary","year":"2019","journal-title":"Infect. Drug. Resist."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.str.2022.07.009","article-title":"Structure-based design of anti-mycobacterial drug leads that target the mycolic acid transporter MmpL3","volume":"30","author":"Hu","year":"2022","journal-title":"Structure"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1038\/s42003-025-09107-3","article-title":"ACA kills Mycobacterium tuberculosis and M. bovis by targeting cell wall core assembling protein CpsA","volume":"8","author":"Huang","year":"2025","journal-title":"Commun. Biol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"e202412994","DOI":"10.1002\/anie.202412994","article-title":"Arenicolide family macrolides provide a new therapeutic lead combating multidrug-resistant tuberculosis","volume":"64","author":"Hwang","year":"2025","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e0314422","DOI":"10.1371\/journal.pone.0314422","article-title":"Benzothiazinone analogs as anti-mycobacterium tuberculosis DprE1 irreversible inhibitors: covalent docking, validation, and molecular dynamics simulations","volume":"19","author":"Ibrahim","year":"2024","journal-title":"Plos. One."},{"key":"B63","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","article-title":"Generic diagramming platform (GDP): a comprehensive database of high-quality biomedical graphics","volume":"53","author":"Jiang","year":"2025","journal-title":"Nucleic. Acids. Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"101348","DOI":"10.1016\/j.cels.2025.101348","article-title":"Integration of multi-modal measurements identifies critical mechanisms of tuberculosis drug action","volume":"16","author":"Johnson","year":"2025","journal-title":"Cell"},{"key":"B65","doi-asserted-by":"publisher","first-page":"7957","DOI":"10.1080\/07391102.2023.2242499","article-title":"Identification of potential inhibitors of Mtb InhA: a pharmacoinformatics approach","volume":"42","author":"Kamera","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B66","doi-asserted-by":"publisher","first-page":"5583342","DOI":"10.1155\/2021\/5583342","article-title":"Antimycobacterial activity, synergism, and mechanism of action evaluation of novel polycyclic amines against Mycobacterium tuberculosis","volume":"2021","author":"Kapp","year":"2021","journal-title":"Adv. Pharmacol. Pharm. Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1002\/jps.24469","article-title":"Coencapsulation of hydrophobic and hydrophilic antituberculosis drugs in synergistic Brij 96 microemulsions: a biophysical characterization","volume":"104","author":"Kaur","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"107718","DOI":"10.1016\/j.jmgm.2020.107718","article-title":"Structure based pharmacophore modelling approach for the design of azaindole derivatives as DprE1 inhibitors for tuberculosis","volume":"101","author":"Kb","year":"2020","journal-title":"J. Mol. Graph. Model."},{"key":"B69","doi-asserted-by":"publisher","first-page":"102008","DOI":"10.1016\/j.tube.2020.102008","article-title":"Solid lipid nanoparticles containing anti-tubercular drugs attenuate the Mycobacterium marinum infection","volume":"125","author":"Khatak","year":"2020","journal-title":"Tuberc. (Edinb)"},{"key":"B70","doi-asserted-by":"publisher","first-page":"12790","DOI":"10.1021\/acs.jmedchem.1c00837","article-title":"1,3-Diarylpyrazolyl-acylsulfonamides as potent anti-tuberculosis agents targeting cell wall biosynthesis in Mycobacterium tuberculosis","volume":"64","author":"Khonde","year":"2021","journal-title":"J. Med. Chem."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1669022","DOI":"10.3389\/fmicb.2025.1669022","article-title":"RapTB: a lung-derived hemoglobin fragment with activity against Mycobacterium tuberculosis","volume":"16","author":"Klevesath","year":"2025","journal-title":"Front. Microbiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3390\/antibiotics10060693","article-title":"Elucidating the antimycobacterial mechanism of action of decoquinate derivative RMB041 using metabolomics","volume":"10","author":"Knoll","year":"2021","journal-title":"Antibiot. (Basel)"},{"key":"B73","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/microorganisms13010021","article-title":"Toward Mycobacterium tuberculosis virulence inhibition: beyond cell wall","volume":"13","author":"Kotliarova","year":"2024","journal-title":"Microorganisms"},{"key":"B74","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41586-025-09286-3","article-title":"SuFEx-based antitubercular compound irreversibly inhibits Pks13","volume":"645","author":"Krieger","year":"2025","journal-title":"Nature"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e2000211","DOI":"10.1002\/minf.202000211","article-title":"Targeting Mycobacterium tuberculosis enoyl-acyl carrier protein reductase using computational tools for identification of potential inhibitor and their biological activity","volume":"40","author":"Kuldeep","year":"2021","journal-title":"Mol. Inf."},{"key":"B76","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.1080\/07391102.2019.1696231","article-title":"Identification of peptidomimetic compounds as potential inhibitors against MurA enzyme of Mycobacterium tuberculosis","volume":"38","author":"Kumar","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B77","doi-asserted-by":"publisher","first-page":"818714","DOI":"10.3389\/fmicb.2022.818714","article-title":"Identifying the novel inhibitors against the mycolic acid biosynthesis pathway target \u201cmtFabH\u201d of Mycobacterium tuberculosis","volume":"13","author":"Kumar","year":"2022","journal-title":"Front. Microbiol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"109506","DOI":"10.1016\/j.carres.2025.109506","article-title":"Synthesis and evaluation of Trehalose-Pks13 inhibitor conjugates targeting mycobacteria","volume":"553","author":"Kumbalathara","year":"2025","journal-title":"Carbohydr. Res. Carbohydr. Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"116938","DOI":"10.1016\/j.bmc.2022.116938","article-title":"Drug screening approach against mycobacterial fatty acyl-AMP ligase FAAL32 renews the interest of the salicylanilide pharmacophore in the fight against tuberculosis","volume":"71","author":"Le","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"B80","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s00203-023-03515-x","article-title":"Novel role of PE_PGRS47 in the alteration of mycobacterial cell wall integrity and drug resistance","volume":"205","author":"Li","year":"2023","journal-title":"Arch. Microbiol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"117416","DOI":"10.1016\/j.ejmech.2025.117416","article-title":"Discovery of novel pyrimidinetrione derivatives as DprE1 inhibitors with potent antimycobacterial activities","volume":"289","author":"Liang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"B82","doi-asserted-by":"publisher","first-page":"115579","DOI":"10.1016\/j.ejmech.2023.115579","article-title":"In vitro bioevaluation and docking study of dihydrosphingosine and ethambutol analogues against sensitive and multi-drug resistant Mycobacterium tuberculosis","volume":"258","author":"Linhares","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"B83","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1038\/s41467-025-58196-5","article-title":"Structural insights into terminal arabinosylation of mycobacterial cell wall arabinan","volume":"16","author":"Liu","year":"2025","journal-title":"Nat. Commun."},{"key":"B84","doi-asserted-by":"publisher","first-page":"102579","DOI":"10.1016\/j.tube.2024.102579","article-title":"Identification of BMVC-8C3O as a novel Pks13 inhibitor with anti-tuberculosis activity","volume":"150","author":"Liu","year":"2025","journal-title":"Tuberc. (Edinb)"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e02190","DOI":"10.1128\/AAC.02190-20","article-title":"Therapeutic potential of coumestan Pks13 inhibitors for tuberculosis","volume":"95","author":"Lun","year":"2023","journal-title":"Antimicrob. Agents. Chemother."},{"key":"B86","doi-asserted-by":"publisher","first-page":"e202515896","DOI":"10.1002\/anie.202515896","article-title":"Chemical synthesis of Arabinogalactans from the Mycobacterium tuberculosis cell wall up to the 92-mer and structure-conformation-activity relationship studies","volume":"64","author":"Ma","year":"2025","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"B87","doi-asserted-by":"publisher","first-page":"115579","DOI":"10.1016\/j.bmc.2020.115579","article-title":"Synthesis and evaluation of heterocycle structures as potential inhibitors of Mycobacterium tuberculosis UGM","volume":"28","author":"Maaliki","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"B88","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1021\/acsnano.8b07902","article-title":"Intrinsic antibacterial activity of nanoparticles made of beta-Cyclodextrins potentiates their effect as drug nanocarriers against tuberculosis","volume":"13","author":"Machelart","year":"2019","journal-title":"ACS. Nano."},{"key":"B89","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.3390\/ijms22062884","article-title":"Mycobacterial epoxide hydrolase EphD is inhibited by urea and thiourea derivatives","volume":"22","author":"Madacki","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B90","doi-asserted-by":"publisher","first-page":"e0238178","DOI":"10.1371\/journal.pone.0238178","article-title":"Dissecting the antibacterial activity of oxadiazolone-core derivatives against Mycobacterium abscessus","volume":"15","author":"Madani","year":"2020","journal-title":"PLoS. One."},{"key":"B91","doi-asserted-by":"publisher","first-page":"6437","DOI":"10.1007\/s11030-025-11152-3","article-title":"New pyrazole-based derivatives targeting MmpL3 transporter in mycobacterium tuberculosis: design, synthesis, biological evaluation and molecular docking studies","volume":"29","author":"Maddipatla","year":"2025","journal-title":"Mol. Divers."},{"key":"B92","doi-asserted-by":"publisher","first-page":"dlab028","DOI":"10.1093\/jacamr\/dlab028","article-title":"Characterization of the MurT\/GatD complex in Mycobacterium tuberculosis towards validating a novel anti-tubercular drug target","volume":"3","author":"Maitra","year":"2021","journal-title":"JAC. Antimicrob. Resist."},{"key":"B93","doi-asserted-by":"publisher","first-page":"16368","DOI":"10.1038\/s41598-022-20325-1","article-title":"Identification of hydantoin based Decaprenylphosphoryl-\u03b2-d-Ribose oxidase (DprE1) inhibitors as antimycobacterial agents using computational tools","volume":"12","author":"Mali","year":"2022","journal-title":"Sci. Rep."},{"key":"B94","doi-asserted-by":"publisher","first-page":"164","DOI":"10.5817\/CSF2021-5-164","article-title":"Telacebec (Q203): is there a novel effective and safe anti-tuberculosis drug on the horizon?","volume":"70","author":"Mal\u00edk","year":"2021","journal-title":"Ceska. Slov. Farm."},{"key":"B95","doi-asserted-by":"publisher","first-page":"7553","DOI":"10.1021\/acs.jmedchem.3c00398","article-title":"Investigation into the mechanism of action of the tuberculosis drug candidate SQ109 and its metabolites and analogues in mycobacteria","volume":"66","author":"Malwal","year":"2023","journal-title":"J. Med. Chem."},{"key":"B96","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1080\/07391102.2024.2438363","article-title":"Phytocompounds hesperidin, rebaudioside a and rutin as drug leads for the treatment of tuberculosis targeting mycobacterial phosphoribosyl pyrophosphate synthetase","volume":"44","author":"Manthattil Vysyan","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B97","doi-asserted-by":"publisher","first-page":"e00985","DOI":"10.1128\/mSphere.00985-20","article-title":"Multiple mutations in Mycobacterium tuberculosis MmpL3 increase resistance to MmpL3 inhibitors","volume":"5","author":"McNeil","year":"2020","journal-title":"mSphere"},{"key":"B98","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1039\/d2md00320a","article-title":"Multi-drug loaded eugenol-based nanoemulsions for enhanced anti-mycobacterial activity","volume":"14","author":"Menon","year":"2023","journal-title":"RSC. Med. Chem."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s11030-022-10511-8","article-title":"Discovery of newer pyrazole derivatives with potential anti-tubercular activity via 3D-QSAR based pharmacophore modelling, virtual screening, molecular docking and molecular dynamics simulation studies","volume":"27","author":"Modi","year":"2023","journal-title":"Mol. Divers."},{"key":"B100","doi-asserted-by":"publisher","first-page":"9472","DOI":"10.1039\/d5sc02565f","article-title":"Tailored phenyl ureas eradicate drug-resistant Mycobacterium tuberculosis by targeting mycolic acid cell wall assembly","volume":"16","author":"Mostert","year":"2025","journal-title":"Chem. Sci."},{"key":"B101","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00203-025-04238-x","article-title":"Targeting InhA in drug-resistant mycobacterium tuberculosis: potent antimycobacterial activity of diaryl ether dehydrozingerone derivatives","volume":"207","author":"Mubarak","year":"2025","journal-title":"Arch. Microbiol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s00203-025-04352-w","article-title":"Mycobacterium tuberculosis curli pili (MTP) and heparin-binding hemagglutinin adhesin (HBHA) facilitate regulation of central carbon metabolism, enhancement of ATP synthesis and cell wall biosynthesis","volume":"207","author":"Naidoo","year":"2025","journal-title":"Arch. Microbiol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1021\/acsinfecdis.4c00119","article-title":"Durlobactam, a diazabicyclooctane \u03b2-Lactamase inhibitor, inhibits BlaC and peptidoglycan transpeptidases of Mycobacterium tuberculosis","volume":"10","author":"Nantongo","year":"2024","journal-title":"ACS. Infect. Dis."},{"key":"B104","doi-asserted-by":"publisher","first-page":"e0137225","DOI":"10.1128\/mbio.01372-25","article-title":"Exploring \u03b2-lactam interactions with DacB1: unraveling optimal therapies for combating drug-resistant Mycobacterium tuberculosis","volume":"16","author":"Nantongo","year":"2025","journal-title":"mBio."},{"key":"B105","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1208\/s12249-019-1334-y","article-title":"Ethambutol-loaded solid lipid nanoparticles as dry powder inhalable formulation for tuberculosis therapy","volume":"20","author":"Nemati","year":"2019","journal-title":"AAPS. PharmSciTech."},{"key":"B106","doi-asserted-by":"publisher","first-page":"107770","DOI":"10.1016\/j.jmgm.2020.107770","article-title":"Virtual screening and free energy estimation for identifying Mycobacterium tuberculosis flavoenzyme DprE1 inhibitors","volume":"102","author":"Niranjan","year":"2021","journal-title":"J. Mol. Graph. Model."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1021\/acsinfecdis.4c01054","article-title":"Discovery of 2,4,5-Substituted benzoxazole derivatives as Pks13 inhibitors via the scaffold hopping strategy","volume":"11","author":"Obadawo","year":"2025","journal-title":"ACS. Infect. Dis."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/cbdd.13739","article-title":"Design, synthesis, and biological evaluation of novel imidazo[1,2-a]pyridinecarboxamides as potent anti-tuberculosis agents","volume":"96","author":"Onajole","year":"2020","journal-title":"Chem. Biol. Drug. Des."},{"key":"B110","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s11030-025-11205-7","article-title":"Identifying potent inhibitors for Mycobacterium tuberculosis MabA (FabG1)","volume":"30","author":"Panda","year":"2026","journal-title":"Mol. Divers."},{"key":"B111","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1039\/c9ob00680j","article-title":"A novel codrug made of the combination of ethionamide and its potentiating booster: synthesis, self-assembly into nanoparticles and antimycobacterial evaluation","volume":"17","author":"Pastor","year":"2019","journal-title":"Org. Biomol. Chem."},{"key":"B112","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s41598-020-57658-8","article-title":"Screening of natural compounds that targets glutamate racemase of Mycobacterium tuberculosis reveals the anti-tubercular potential of flavonoids","volume":"10","author":"Pawar","year":"2020","journal-title":"Sci. Rep."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.4155\/fmc-2023-0096","article-title":"Novel pyrimidine-1,3,4-oxadiazole hybrids and their precursors as potential antimycobacterial agents","volume":"15","author":"Pfl\u00e9gr","year":"2023","journal-title":"Future. Med. Chem."},{"key":"B114","doi-asserted-by":"publisher","first-page":"113668","DOI":"10.1016\/j.ejmech.2021.113668","article-title":"Design and synthesis of 2-(2-isonicotinoylhydrazineylidene)propanamides as InhA inhibitors with high antitubercular activity","volume":"223","author":"Pfl\u00e9gr","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"B115","doi-asserted-by":"publisher","first-page":"e0324608","DOI":"10.1371\/journal.pone.0324608","article-title":"5-(3,5-Dinitrophenyl)-1,3,4-oxadiazol-2-amine derivatives, their precursors, and analogues: synthesis and evaluation of novel highly potent antitubercular agent","volume":"20","author":"Pfl\u00e9gr","year":"2025","journal-title":"PLOS. One."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1080\/10717544.2019.1676841","article-title":"Active pulmonary targeting against tuberculosis (TB) via triple-encapsulation of Q203, bedaquiline and superparamagnetic iron oxides (SPIOs) in nanoparticle aggregates","volume":"26","author":"Poh","year":"2019","journal-title":"Drug. Deliv."},{"key":"B117","doi-asserted-by":"publisher","first-page":"6020","DOI":"10.1039\/d5md00637f","article-title":"Tanshinones target drug-resistant tuberculosis: efficacy, selectivity, and potential mechanism of action","volume":"16","author":"Polin\u00e1rio","year":"2025","journal-title":"RSC. Med. Chem."},{"key":"B118","doi-asserted-by":"publisher","first-page":"29547","DOI":"10.1021\/acsomega.5c02912","article-title":"Designing novel InhA inhibitors for antituberculosis agents using ab initio fragment molecular orbital calculations","volume":"10","author":"Pornprom","year":"2025","journal-title":"ACS. Omega."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s13346-021-01003-7","article-title":"Mannose-conjugated chitosan nanoparticles for delivery of rifampicin to osteoarticular tuberculosis","volume":"11","author":"Prabhu","year":"2021","journal-title":"Drug. Deliv. Transl. Res."},{"key":"B120","doi-asserted-by":"publisher","first-page":"e0059723","DOI":"10.1128\/aac.00597-23","article-title":"Drug distribution and efficacy of the DprE1 inhibitor BTZ-043 in the C3HeB\/FeJ mouse tuberculosis model","volume":"67","author":"Ramey","year":"2023","journal-title":"Antimicrob. Agents. Chemother."},{"key":"B121","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1021\/acs.jmedchem.4c01844","article-title":"Identification of an isoxazole derivative as an antitubercular compound for targeting the FadD enzymes of Mycobacterium tuberculosis","volume":"68","author":"Rani","year":"2025","journal-title":"J. Med. Chem."},{"key":"B122","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1080\/07391102.2020.1867641","article-title":"Ensemble-based high-throughput virtual screening of natural ligands using the super Natural-II database against cell-wall protein dTDP-4-dehydrorhamnose reductase (RmlD) in Mycobacterium tuberculosis","volume":"40","author":"Ravichandran","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B123","doi-asserted-by":"publisher","first-page":"e0058321","DOI":"10.1128\/AAC.00583-21","article-title":"Comparative analysis of pharmacodynamics in the C3HeB\/FeJ mouse tuberculosis model for DprE1 inhibitors TBA-7371, PBTZ169, and OPC-167832","volume":"65","author":"Robertson","year":"2021","journal-title":"Antimicrob. Agents. Chemother."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.3390\/molecules22101697","article-title":"Nano-formulation of ethambutol with multifunctional graphene oxide and magnetic nanoparticles retains its anti-tubercular activity with prospects of improving chemotherapeutic efficacy","volume":"22","author":"Saifullah","year":"2017","journal-title":"Molecules"},{"key":"B125","doi-asserted-by":"publisher","first-page":"RP94982","DOI":"10.7554\/eLife.94982","article-title":"Maintenance of cell wall remodeling and vesicle production are connected in Mycobacterium tuberculosis","volume":"13","author":"Salgueiro-Toledo","year":"2025","journal-title":"Elife"},{"key":"B126","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1021\/acsinfecdis.4c00415","article-title":"Development and evaluation of bis-benzothiazoles as a new class of benzothiazoles targeting DprE1 as antitubercular agents","volume":"10","author":"Samoon","year":"2024","journal-title":"ACS. Infect. Dis."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1205829","DOI":"10.3389\/fcimb.2023.1205829","article-title":"Amidation of glutamate residues in mycobacterial peptidoglycan is essential for cell wall cross-linking","volume":"13","author":"Shaku","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1021\/acsmedchemlett.1c00652","article-title":"Development of 6-Methanesulfonyl-8-nitrobenzothiazinone based antitubercular agents","volume":"13","author":"Shi","year":"2022","journal-title":"ACS. Med. Chem. Lett."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.2147\/IJN.S102488","article-title":"Phytogenic silver, gold, and bimetallic nanoparticles as novel antitubercular agents","volume":"11","author":"Singh","year":"2016","journal-title":"Int. J. Nanomedicine."},{"key":"B130","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2217\/nnm-2018-0278","article-title":"Solid lipid nanoparticles for ocular delivery of isoniazid: evaluation, proof of concept and in vivo safety and kinetics","volume":"14","author":"Singh","year":"2019","journal-title":"Nanomedicine (Lond)."},{"key":"B131","doi-asserted-by":"publisher","first-page":"2403744","DOI":"10.1080\/14756366.2024.2403744","article-title":"Novel hybrids of 1,2,3-triazole-benzoxazole: design, synthesis, and assessment of DprE1 enzyme inhibitors using fluorometric assay and computational analysis","volume":"39","author":"Singh","year":"2024","journal-title":"J. Enzyme. Inhib. Med. Chem."},{"key":"B132","doi-asserted-by":"publisher","first-page":"2105236","DOI":"10.1155\/sci5\/2105236","article-title":"A computational approach to repurposing natural products for DprE1 inhibition","volume":"2025","author":"Snehalatha","year":"2025","journal-title":"Sci. (Cairo)"},{"key":"B133","doi-asserted-by":"publisher","first-page":"129583","DOI":"10.1016\/j.ijbiomac.2024.129583","article-title":"MSMEG_0311 is a conserved essential polar protein involved in mycobacterium cell wall metabolism","volume":"260","author":"Sodani","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s42485-021-00065-y","article-title":"Discovering mycobacterial lectins as potential drug targets and vaccine candidates for tuberculosis treatment: a theoretical approach","volume":"12","author":"Sundar","year":"2021","journal-title":"J. Proteins. Proteom."},{"key":"B135","doi-asserted-by":"publisher","first-page":"6280","DOI":"10.1080\/07391102.2023.2233622","article-title":"Structure based virtual screening and discovery of novel inhibitors against FabD protein of Mycobacterium tuberculosis","volume":"42","author":"Sundararajan","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1007\/s11095-009-9894-2","article-title":"Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery","volume":"26","author":"Sung","year":"2009","journal-title":"Pharm. Res."},{"key":"B137","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41429-020-0293-6","article-title":"Improvement of the novel inhibitor for mycobacterium enoyl-acyl carrier protein reductase (InhA): a structure-activity relationship study of KES4 assisted by in silico structure-based drug screening","volume":"73","author":"Taira","year":"2020","journal-title":"J. Antibiot. (Tokyo)"},{"key":"B138","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1080\/07391102.2023.2294496","article-title":"3D-QSAR and ADMET studies of morpholino-pyrimidine inhibitors of DprE1 from Mycobacterium tuberculosis","volume":"43","author":"Tayal","year":"2025","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B139","doi-asserted-by":"publisher","first-page":"118324","DOI":"10.1016\/j.ejmech.2025.118324","article-title":"Advancing the antituberculosis activity of nitropicolinic acids and amides","volume":"302","author":"Thompson","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s11030-019-09990-z","article-title":"Design, synthesis, in silico and in vitro evaluation of novel diphenyl ether derivatives as potential antitubercular agents","volume":"24","author":"Tiwari","year":"2020","journal-title":"Mol. Divers."},{"key":"B141","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.2217\/nnm-2017-0248","article-title":"Targeted macrophages delivery of rifampicin-loaded lipid nanoparticles to improve tuberculosis treatment","volume":"12","author":"Vieira","year":"2017","journal-title":"Nanomedicine (Lond)."},{"key":"B142","doi-asserted-by":"publisher","first-page":"6162","DOI":"10.3390\/molecules26206162","article-title":"In silico identification of possible inhibitors for protein kinase B (PknB) of Mycobacterium tuberculosis","volume":"26","author":"Vieira","year":"2021","journal-title":"Molecules"},{"key":"B143","doi-asserted-by":"publisher","first-page":"146193","DOI":"10.1016\/j.ijbiomac.2025.146193","article-title":"Mycobacterial phthiocerol dimycocerosate induces Galectin-3 upregulation to impair proinflammatory responses and favor immune evasion","volume":"321","author":"Wang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"B109","volume-title":"Global Tuberculosis Report 2025","year":"2025"},{"key":"B144","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.3390\/microorganisms13102245","article-title":"Mycobacterium transcriptional factor BlaI regulates cell division and growth and potentiates beta-lactam antibiotic efficacy against mycobacteria","volume":"13","author":"Xu","year":"2025","journal-title":"Microorganisms"},{"key":"B145","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1080\/07391102.2022.2036241","article-title":"Design, synthesis, and computational studies of benzimidazole derivatives as new antitubercular agents","volume":"41","author":"Yalcin-Ozkat","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B146","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s00253-025-13588-x","article-title":"Generation of novel polyclonal antibodies against Mycobacterium tuberculosis lipoarabinomannan, EspB, and Mtb8","volume":"109","author":"Yan","year":"2025","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"22745","DOI":"10.1039\/d5ra01362c","article-title":"Insights into anti-tuberculosis drug design on the scaffold of nitroimidazole derivatives using structure-based computer-aided approaches","volume":"15","author":"Yang","year":"2025","journal-title":"RSC. Adv."},{"key":"B148","doi-asserted-by":"publisher","first-page":"e0247721","DOI":"10.1128\/spectrum.02477-21","article-title":"Sudapyridine (WX-081), a novel compound against Mycobacterium tuberculosis","volume":"10","author":"Yao","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"B149","doi-asserted-by":"publisher","first-page":"106883","DOI":"10.1016\/j.bioorg.2023.106883","article-title":"Design, synthesis, in vitro and in silico evaluation of novel substituted 1,2,4-triazole analogues as dual human VEGFR-2 and TB-InhA inhibitors","volume":"141","author":"Zawal","year":"2023","journal-title":"Bioorg. Chem."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1637254","DOI":"10.3389\/fmicb.2025.1637254","article-title":"Progress of anti-tuberculosis drug targets and novel therapeutic strategies","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Microbiol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"e0036825","DOI":"10.1128\/aac.00368-25","article-title":"Microbiological evidence for the trisubstituted benzimidazoles targeting MmpL3 in mycobacterium tuberculosis. Antimicrob agents chemother. Antimicrob. Agents","volume":"69","author":"Zhang","year":"2025","journal-title":"Chemother."},{"key":"B152","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.3390\/microorganisms11102469","article-title":"Telacebec interferes with virulence lipid biosynthesis protein expression and sensitizes to other antibiotics","volume":"11","author":"Zhou","year":"2023","journal-title":"Microorganisms"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1863735\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T05:37:58Z","timestamp":1781501878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1863735\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":152,"alternative-id":["10.3389\/fphar.2026.1863735"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1863735","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"article-number":"1863735"}}